Hepatitis C virus transmission dynamics in injection drug users

Substance Use and Misuse

Volumn 33, Issue 5, 1998, Pages 1197-1212

  Hagan, Holly ^a,b  

^a PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Drug injection; Epidemiology; Hepatitis viruses; Molecular epidemiology

Indexed keywords

HEALTH PROGRAM; HEPATITIS C; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; UNITED STATES; VIRUS TRANSMISSION;

EID: 0031807856     PISSN: 10826084     EISSN: None     Source Type: Journal    
DOI: 10.3109/10826089809062214     Document Type: Review

References (58)

1. ANDERSON, R. M., and MAY, R. M. (1995). Infectious Diseases in Humans. London: Oxford University Press.
2. BENENSON, A. S. (Ed.) (1990). Control of Communicable Diseases in Man, 15th ed. Washington, D.C.: American Public Health Association Publ.ications.
3. BORTOLOTTI, F., CADROBBI, P., CRIVELLARO, C., MENENGHETTI, F., CARRETTA, M., STIVANELLO, A., DE ROSSI, A., and NOVENTA, F. (1989). The changing epidemiology of acute type B hepatitis: Results of an 11-year prospective study in Padua (Northern Italy). Infection 17: 18-22.
4. BRESTERS, D., MAUSER-BUNSCHOTEN, E. P., REESINK, H. W., et al. (1993). Sexual transmission of hepatitis C virus. Lancet 342: 210-211.
5. BUNING, E. C. (1991). Effects of Amsterdam needle and syringe exchange. Int. J. Addict. 26: 1303-1311.
6. CHAMOT, E., DE SAUSSURE, PH., HIRSCHEL, B., DEGLON, J. J., and PERRIN, L. H. (1992). Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS 6: 431-432.
7. CHEMELLO, L., ALBERTI, A., ROSE, K., and SIMMONDS, P. (1994). Hepatitis C serotype and response to interferon therapy. New Engl. J. Med. 330: 143.
8. CONRAD, E. U., GRETCH, D. R., OBERMEYER, K. R., et al. (1995). The transmission of hepatitis C virus by tissue transplantation. J. Bone Jt. Surg. 72: 214-224.
9. CROFTS, N., HOPPER, J., KELSALL, J., KERGER, M., GERTIG, D., and LOCARNINI, S. (1993). Blood-borne viruses among Australian injecting drug users (IDUs): Implications for spread of HIV. Proc. 9th Int. Conf. AIDS, Berlin, Germany.
10. CROFTS, N., STEWART, T., HEARNE, P., PANG, Y. X., BRESCHKIN, A. M., and LOCARNINI, S. (1995). Spread of bloodborne viruses among Australian prison entrants. Br. Med. J. 310: 285-288.
11. DELGADO-IRIBARREN, A., PADILLA, B., GOMEZ RODRIGO, J., and ELVIRO, J. (1991). Hepatitis C virus (HCV) antibodies among intravenoue drug abusers and association with human immunodeficiency virus (HIV) antibodies. Proc. 7th Int. Conf. AIDS, Florence, Italy.
12. DUSHEIKO, G., SCHMILOVITZWEISS, H., BROWN, D., et al. (1994). Hepatitis C virus genotypes - An investigation of type-specific differences in geographic origin and disease. Hepatology 19: 13-18.
13. ESTEBAN, J. L., LOPEZ-TALAVERA, J. C., GENESCA, J., et al. (1992). High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann. Intern. Med. 115: 443-449.
14. EVANS, A. S. (Ed.) (1991). Viral Infections in Humans, 3rd ed. New York, NY: Plenum.
15. FARCI, P., ALTER, H. J., GOVINDAARAAJAN, S., et al. (1992). Lack of protective immunity against reinfection with hepatitis C virus. Science 258: 135-140.
16. HAGAN, H., DES JARLAIS, D. C., FRIEDMAN, S. R., PURCHASE, D., and ALTER, M. J. (1995). Reduced risk of hepatitis B among participants in a syringe exchange program. Am. Public Health 85: 1531-1537.
17. HAGAN, H., DES JARLAIS, D. C., PURCHASE, D., FRIEDMAN, S. R., REID, T. R., and BELL, T. A. (1991). JAMA 266: 1646-1647.
18. HAGAN, H., MCGOUGH, J., HANSEN, G., YU T. J., FIELDS, M. J., and ALEXANDER, E. R. (1996). Incidence of bloodborne viruses in a cohort of injection drug users. Proc. 11th Int. Conf. AIDS, Vancouver, BC, Canada.
19. HANSON, G. R., MCGOUGH, J. P., FIELDS, J., et al. (1995). Risk factors and prevalence of hepatitis C subtypes among injection drug users in Seattle, King County, Washington. Proc. 123rd Annu. Meet. APHA, San Diego, CA, USA.
20. HART, G. J., WOODWARD, N., JOHNSON, A. M., TIGHE, J., PARRY, J. V., and ADLER, M. W. (1991). Prevalence of HIV, hepatitis B and associated risk behaviors in clients of a needle-exchange in central London. AIDS 5: 543-547.
21. HOFMAN, H. (1995). Genotypes and virus load in patients with hepatitis C. Infection 23: 133-138.
22. KUIKEN, C. L., ZWART, G., BAAN, E., COUTINHO, R. A., VAN DEN HOEK, J. A. R., and GOUDSMIT, (1993). Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc. Natl. Acad. Sci. U.S.A. 90: 9061-9065.
23. LAI, M. E., MAZZOLENI, A. P., ARGIOLU, F., et al. (1994). Hepatitis C virus in multiple episodes of acute hepatitis in transfused thalassaemic children. Lancet 343: 388-390.
24. LAST, J. M. (Ed.) (1983). A Dictionary of Epidemiology. New York, NY: Oxford University Press.
25. LECESSE, V., D'AGOSTINO, S., AGOSTINO, N., ZANCHI, L., and TIEPOLO, F. (1993). HIV/hepatitis B (HBV) seroprevalence and behavioral changes among intravenoue drug (IVD) users in Biella Italy, 1979-1992. Proc. 9th Int. Conf. AIDS, Berlin, Germany.
26. LEVINE, O. S., VLAHOV, D., BROOKMEYER, R., COHN, S., and NELSON, K. E. (1996). Differences in the incidence of hepatitis B and HIV infections among injecting drug users. J. Infect. Dis. 173: 579-583.
27. LEVINE, O. S., VLAHOV, D., KOEHLER, J., COHN, S., SPRONK, A. M., and NELSON, K. E. (1995). Seroepidemiology of hepatitis B virus in a population of injecting drug users: Association with drug injection patterns. Am. J. Epidemiol. 142: 331-341.
28. LEVINE, O. S., VLAHOV, D., and NELSON, K. E. (1994). Epidemiology of hepatitis B virus infections among injecting drug users: Seroprevalence, risk factors, and viral interactions. Epidemiol. Rev. 16: 418-436.
29. LOVE, A., SIGURDSSON, L. R., STANZEIT, B., BRIEM, H., RIKARDSDOTTIR, H., and WIDELL, (1996). Characteristics of hepatitis C in intravenous drug users in Iceland. Am. J. Epidemiol. 143: 631-636.
30. MAJID, A., HOLMES, R., DESSELBERGER, U., SIMMONDS, P., and MCKEE, T. A. (1995). Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J. Med. Virol. 46: 48-51.
31. MALLIORI, M., HATZZAKIS, A., KATSOULIDOU, A., TOULOUMI, P., and STEFANIS, C. (1993). Hepatitis C virus (HCV) seroeideliology provides important insight in the understanding of the spread of HIV epidemic in intravenous drug users. Proc. 9th Int. Conf. AIDS, Berlin, Germany.
32. MANDELLI, C., CESANA, M., FERRONI, P., LORINI, G. P., AIMO, G. P., TAGGER, A., BIANCHI, A., and CONTE, D. (1988). HBV, HDV and HIV infections in 242 drug addicts; Two-year follow-up. Eur. J. Epidemiol. 4: 318-321.
33. MELE, A. BIANCOLILLI, V., D'ARGENIO, P., and SAGLIOCCA, L. (1993). Considerations on markers of hepatitis B, C and HIV as indicators of risk behavior in intravenous drug users. J. Public Health Med. 15: 112.
34. POLAKOFF, S. (1987). Decrease in acute hepatitis B incidence in England and Wales in 1985-86. Lancet 329: 380.
35. POLAKOFF, S. (1988). Decrease in acute hepatitis B incidence continued in 1987. Lancet 331: 540.
36. ROMANO, N., VITALE, F., RUSSO ALESI, D., BONURA, F., LA LICATA, F., INTONAZZO, V., DARDANONI, G., and MAMMINA, C. (1992). The changing pattern of human immunodeficiency virus type 1 infection in intravenous drug users. Am. J. Epidemiol. 135: 1189-1196.
37. SHEV, V., WIDELL, A., BERGSTROM, T., HERMONDSSON, S., LINDHOLM, A., and NORKRANS, (1995). Herpes simplex virus-2 may increase susceptibility of the sexual transmission of hepatitis C. Sex. Transmitted Dis. 22: 210-216.
38. SHULTE, P. A., and PEREIRA, F. P. (Eds.) (1993). Molecular Epidemiology. San Diego, CA: Academic Press.
39. SILINI, E., BONO, F., CIVIDINI, A., et al. (1995). Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J. Hepatol. 22: 691-695.
40. SIMMONDS, P. (1995). Variability of hepatitis C virus. Hepatology 21: 570-583.
41. SIMMONDS, P., HOLMES, E. C., CHA, T. A., et al. (1993). Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74: 2391-2399.
42. SOTO, B., RODRIGO, L., GARCIA-BENGOECHEA, M., et al. (1994). Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. J. Intern. Med. 236: 515-519.
43. STARK, K., MULLER, R., GUGGENMOOS-HOLZMANN, I., DEININGER, S., MEYER, E., and BIENZLE, U. (1990). HIV infection in intravenous drug abusers in Berlin: Risk factors and time trends. Klin. Wochenschr. 68: 415.
44. SWENSEN, G., QUIGLEY, A., and LENTON, S. (1990). Hepatitis B infection - A proxy measure of risk factors for HIV infection in IVDUs? Med. J. Aust. 153: 434-435.
45. TITTI, F., REZZA, G., VERANI, P., BUTTO, S., SERNICOLA, L., RAPICETTA, M., SARRECCHIA, B., OLIVA, C., and ROSSI, G. B. (1988). HIV, HTLV-1, and HBV infections in a cohort of Italian intravenous drug abusers: Analysis of risk factors. J. Acquired Immune Deficiency Syndromes 1: 405-411.
46. TOR, J., LLIBRE, J. M., CARBONELL, M., MUGA, R., RIBERA, A., SORIANO, V., CLOTET, B., SABRIA, M., and FOX, M. (1990). Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. Br. Med. J. 301: 30-33.
47. VAN AMEIJDEN, E., VAN DEN HOEK, J. A. R., MIENTJES, G. H. C., and COUTINHO, R. A. (1991). Monitoring the HIV-epidemic among drug users in Amsterdam: The value of HBV and HCV as surrogate markers. Proc. 7th Int. Conf. AIDS, Florence, Italy.
48. VAN BEEK, I., KALDOR, J., BUCKLEY, R., STEWART, M., and MACDONALD, M. (1993). Hepatitis C virus infection indicates HIV risk behavior but not necessarily HIV transmission among injecting drug users. Proc. 9th Int. Conf. AIDS, Berlin, Germany.
49. VAN DEN HOEK, J. A. R., VAN HAASTRECHT, H. J. A., GOUDSMlT, J., DE WOLF, F., and COUTINHO, A. (1990). Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J. Infect. Dis. 162: 823-826.
50. VENTURINI, L., LUGOBONI, F., FIBBIA, G. C., QUAGLIO, G. L., MEZZELANI, P., and DES JARLAIS, D. C. (1993). Relationships between serological markers for HIV, HBV and HCV among injecting drug userrs in northeast Italy. Proc. 9th Int. Conf. AIDS, Berlin, Germany.
51. WATANABE, M., OHKOSHI, S., TWARAYA, H., et al. (1994). Hepatitis C viral markers in patients who received blood that was positive for hepatitis core antibody, with genetic evidence of hepatitis C virus transmission. Transfusion 34: 125-129.
52. WEINER, A. J., GEYSEN, H. M., CHRISTOPHERSON, C., et al. (1992). Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc. Natl. Acad. Sci. U.S.A. 89: 3468-3472.
53. WESTH, H., WORM, A.-M., JENSEN, B. L., KROON, S., KVINESDAL, B., NIELSEN, C. M., and WANTZIN, P. (1993). Hepatitis C virus antibodies in homosexual men and intravenous drug users. Infection 46: 115-117.
54. WODAK, A., and CROFTS, N. (1996). Once more into the breach: Controlling hepatitis C in injecting drug users. Addiction 91: 181-184.
55. WOODFIELD, D. G., HARNESS, M., RIX-TROTT, K., TSUDA, F., OKAMOTO, H., and MAYUMI, (1994). Identification and genotyping of hepatitis C virus in injection and oral drug users in New Zealand. Aust. N.Z.J. Med. 24: 47-50.
56. YAMADA, G., TAKAHASHI, M., MIYAMORO, R., et al. (1994). Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA, Dig. Dis. Sci. 39: 441-449.
57. ZELDIS, J. B., JAIN, S., KURAMOTO, I. K. RICHARDS, C., SAZAMA, K., SAMUELS, S., HOLLAND, P. V., and FLYNN, N. (1992). Seroepidemiology of viral infections among intravenous drug users in northern California. West J. Med. 156: 30-35.
58. ZERJAV, S. (1990). HIV and HBV infection among i.v. drug abusers in Belgrade (Yugoslavia). Proc. 6th Int. Conf. AIDS, San Francisco, CA, USA.